UPDATE: Morgan Stanley Reiterates Overweight Rating, Removes PT on Envision Healthcare Holdings as 2014 is Shaping Up For Continued Growth

In a report published Thursday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on

, but removed the $33.00 price target. In the report, Morgan Stanley noted, “EVHC experienced a positive mix shift in January. Specifically, the company noted a positive shift of self-pay volumes to Medicaid in a ‘dozen or more' expansion states in January, with some reporting a few hundred bps shift with others at 300 to 400 bps. While the company stated it is too early to parse the data into Medicaid and Exchange buckets, we view the commentary as an early positive sign for reform.” Envision Healthcare Holdings closed on Wednesday at $34.28.